Rankings
▼
Calendar
LQDA
Liquidia Corporation
$3B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$15M
Net Income
-$15M
EPS (Diluted)
$-0.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$91M
Total Liabilities
$26M
Stockholders' Equity
$65M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$15M
-$13M
-11.2%
Net Income
-$15M
-$13M
-11.5%
← FY 2020
All Quarters
Q4 2020 →
LQDA Q3 2020 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena